Skip to main content
Clinical Trials/ISRCTN87011615
ISRCTN87011615
Completed
未知

A prospective open randomised controlled trial of women diagnosed with premature ovarian failure (POF) to investigate the effects of active treatment with hormone replacement therapy (HRT) or combined oral contraceptive pill (COCP), and observation of patients who choose to have no treatment, on bone density, markers of cardiovascular disease, markers of bone metabolism, menopausal symptoms, quality of life, depression score, sexual function and ovarian function over two years

King's College London (UK)0 sites66 target enrollmentJanuary 26, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Premature ovarian failure
Sponsor
King's College London (UK)
Enrollment
66
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Registry
who.int
Start Date
January 26, 2009
End Date
September 1, 2011
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
King's College London (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 18\-44 years
  • 2\. Women with a diagnosis of premature ovarian failure (POF) within the last 36 months (with documented follicle\-stimulating hormone \[FSH] level \>30 IU on 2 occasions 4\-8 weeks apart)
  • 3\. Ability to understand English
  • 4\. Written informed consent for participation in the trial
  • 5\. Not taking hormone medication (HRT/COCP/natural preparations) for 2 months prior to commencement in the trial

Exclusion Criteria

  • 1\. Age less than 18 or over 45 years
  • 2\. Current desire for pregnancy is an exclusion criterion from the active treatment group (as she may be randomised to take COCP). However, she could elect to take part in the no treatment group.
  • 3\. Women with absolute contraindications to hormone treatment will be excluded from the active treatment group (i.e. personal history of thromboembolic disease, oestrogen dependent malignancies, and personal history of focal migraine)
  • 4\. Women taking medication for high cholesterol or found to have raised cholesterol levels on initial assessment
  • 5\. Untreated thyroid disease

Outcomes

Primary Outcomes

Not specified

Similar Trials